| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Preoptic Area | 35 | 2022 | 132 | 6.600 |
Why?
|
| Hypothalamus | 53 | 2018 | 1003 | 5.110 |
Why?
|
| Periodicals as Topic | 22 | 2019 | 1463 | 3.650 |
Why?
|
| Sleep | 52 | 2022 | 4815 | 3.350 |
Why?
|
| Body Temperature Regulation | 13 | 2021 | 292 | 3.170 |
Why?
|
| Neurons | 103 | 2024 | 9515 | 3.150 |
Why?
|
| Wakefulness | 29 | 2024 | 1282 | 3.010 |
Why?
|
| Neurosciences | 16 | 2012 | 384 | 2.980 |
Why?
|
| Neurology | 11 | 2022 | 785 | 2.920 |
Why?
|
| Circadian Rhythm | 29 | 2024 | 2593 | 2.780 |
Why?
|
| Hypercapnia | 5 | 2024 | 259 | 2.450 |
Why?
|
| Peer Review, Research | 9 | 2014 | 343 | 2.400 |
Why?
|
| Suprachiasmatic Nucleus | 13 | 2024 | 141 | 2.270 |
Why?
|
| Fever | 18 | 2020 | 1607 | 2.070 |
Why?
|
| Neural Pathways | 63 | 2020 | 3079 | 2.030 |
Why?
|
| Publishing | 14 | 2019 | 837 | 1.950 |
Why?
|
| Glutamic Acid | 13 | 2022 | 1181 | 1.890 |
Why?
|
| Arousal | 14 | 2022 | 1174 | 1.790 |
Why?
|
| Sleep, REM | 15 | 2024 | 593 | 1.660 |
Why?
|
| Hydrocephalus, Normal Pressure | 3 | 2017 | 101 | 1.560 |
Why?
|
| Pons | 29 | 2013 | 239 | 1.410 |
Why?
|
| Brain Stem | 21 | 2024 | 858 | 1.400 |
Why?
|
| Rats | 141 | 2019 | 23717 | 1.380 |
Why?
|
| Receptors, Prostaglandin E, EP3 Subtype | 6 | 2020 | 23 | 1.370 |
Why?
|
| Neuropeptides | 21 | 2013 | 950 | 1.320 |
Why?
|
| Afferent Pathways | 18 | 2012 | 303 | 1.310 |
Why?
|
| Lipopolysaccharides | 17 | 2020 | 2214 | 1.230 |
Why?
|
| Body Temperature | 13 | 2021 | 780 | 1.210 |
Why?
|
| Hypothalamic Area, Lateral | 14 | 2019 | 108 | 1.140 |
Why?
|
| Autonomic Nervous System | 10 | 2016 | 707 | 1.130 |
Why?
|
| Animals | 245 | 2024 | 168930 | 1.100 |
Why?
|
| Neuroanatomy | 4 | 2016 | 73 | 1.080 |
Why?
|
| Sleep Deprivation | 6 | 2019 | 848 | 1.060 |
Why?
|
| Rats, Sprague-Dawley | 65 | 2019 | 8106 | 1.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 8 | 2018 | 46 | 1.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 26 | 2015 | 582 | 1.000 |
Why?
|
| Receptors, Prostaglandin E | 5 | 2008 | 56 | 0.970 |
Why?
|
| Editorial Policies | 4 | 2015 | 458 | 0.970 |
Why?
|
| Galanin | 9 | 2021 | 42 | 0.960 |
Why?
|
| Medulla Oblongata | 22 | 2016 | 247 | 0.950 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 7 | 2008 | 14 | 0.940 |
Why?
|
| Carbon Dioxide | 4 | 2024 | 1138 | 0.920 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 14 | 2018 | 121 | 0.890 |
Why?
|
| Melanins | 9 | 2016 | 291 | 0.890 |
Why?
|
| Spinal Cord | 28 | 2016 | 1811 | 0.880 |
Why?
|
| gamma-Aminobutyric Acid | 12 | 2024 | 1139 | 0.870 |
Why?
|
| Synaptic Transmission | 13 | 2024 | 1175 | 0.850 |
Why?
|
| Smoke | 2 | 2015 | 243 | 0.840 |
Why?
|
| Hypothalamic Hormones | 5 | 2016 | 145 | 0.810 |
Why?
|
| Pituitary Hormones | 5 | 2016 | 182 | 0.810 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 15 | 2013 | 2885 | 0.810 |
Why?
|
| Industry | 2 | 2015 | 362 | 0.800 |
Why?
|
| Dinoprostone | 7 | 2016 | 597 | 0.800 |
Why?
|
| Perceptual Disorders | 1 | 2024 | 199 | 0.790 |
Why?
|
| Immunohistochemistry | 46 | 2015 | 11061 | 0.790 |
Why?
|
| Cell Count | 25 | 2015 | 1826 | 0.780 |
Why?
|
| Aggression | 3 | 2018 | 748 | 0.760 |
Why?
|
| Efferent Pathways | 20 | 2016 | 164 | 0.750 |
Why?
|
| Calcitonin Gene-Related Peptide | 8 | 2024 | 327 | 0.750 |
Why?
|
| Nerve Net | 11 | 2018 | 2307 | 0.750 |
Why?
|
| Brain | 53 | 2022 | 27159 | 0.750 |
Why?
|
| Central Nervous System | 10 | 2017 | 1345 | 0.750 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 2018 | 179 | 0.740 |
Why?
|
| Narcolepsy | 7 | 2013 | 200 | 0.720 |
Why?
|
| Heating | 1 | 2021 | 103 | 0.710 |
Why?
|
| Biomedical Research | 5 | 2024 | 3459 | 0.700 |
Why?
|
| REM Sleep Behavior Disorder | 5 | 2013 | 111 | 0.700 |
Why?
|
| Alzheimer Disease | 14 | 2021 | 8717 | 0.690 |
Why?
|
| Hypothalamic Diseases | 3 | 2021 | 132 | 0.680 |
Why?
|
| Research Personnel | 2 | 2015 | 589 | 0.660 |
Why?
|
| Parvalbumins | 6 | 2013 | 256 | 0.650 |
Why?
|
| Bankruptcy | 1 | 2019 | 26 | 0.630 |
Why?
|
| Antibodies | 7 | 2024 | 2421 | 0.620 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 7 | 2004 | 319 | 0.620 |
Why?
|
| Cholinergic Fibers | 9 | 2006 | 68 | 0.610 |
Why?
|
| Prostaglandins | 5 | 2012 | 398 | 0.610 |
Why?
|
| Hippocampus | 14 | 2019 | 3776 | 0.590 |
Why?
|
| Appetite Regulation | 2 | 2016 | 84 | 0.580 |
Why?
|
| Dendritic Spines | 1 | 2019 | 244 | 0.580 |
Why?
|
| Cerebral Cortex | 28 | 2016 | 5753 | 0.570 |
Why?
|
| Motor Activity | 9 | 2020 | 2711 | 0.560 |
Why?
|
| Actigraphy | 5 | 2015 | 526 | 0.560 |
Why?
|
| Drinking Behavior | 1 | 2017 | 102 | 0.550 |
Why?
|
| Locus Coeruleus | 9 | 2024 | 241 | 0.550 |
Why?
|
| Forkhead Transcription Factors | 1 | 2024 | 1627 | 0.540 |
Why?
|
| Biological Clocks | 3 | 2008 | 320 | 0.540 |
Why?
|
| Mice | 51 | 2024 | 81889 | 0.530 |
Why?
|
| Epilepsies, Partial | 3 | 2014 | 431 | 0.530 |
Why?
|
| Writing | 2 | 2016 | 200 | 0.530 |
Why?
|
| Thirst | 1 | 2016 | 42 | 0.530 |
Why?
|
| Solitary Nucleus | 3 | 2016 | 54 | 0.530 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2014 | 44 | 0.520 |
Why?
|
| Norepinephrine | 5 | 2012 | 898 | 0.520 |
Why?
|
| Atrial Natriuretic Factor | 10 | 1995 | 350 | 0.520 |
Why?
|
| Journal Impact Factor | 2 | 2014 | 157 | 0.520 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 388 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 22 | 2005 | 4400 | 0.510 |
Why?
|
| Rod Opsins | 3 | 2014 | 108 | 0.510 |
Why?
|
| Medicare | 3 | 2019 | 6820 | 0.510 |
Why?
|
| Prostaglandin D2 | 2 | 2014 | 109 | 0.510 |
Why?
|
| School Admission Criteria | 1 | 2016 | 106 | 0.500 |
Why?
|
| Visceral Afferents | 3 | 2015 | 9 | 0.500 |
Why?
|
| Feedback, Physiological | 2 | 2016 | 481 | 0.500 |
Why?
|
| Periaqueductal Gray | 4 | 2013 | 111 | 0.500 |
Why?
|
| Health Care Reform | 2 | 2015 | 1256 | 0.490 |
Why?
|
| Neurologic Examination | 1 | 2018 | 913 | 0.490 |
Why?
|
| Drinking | 1 | 2016 | 196 | 0.490 |
Why?
|
| Disclosure | 2 | 2014 | 755 | 0.480 |
Why?
|
| Humans | 165 | 2024 | 766766 | 0.480 |
Why?
|
| Cholera Toxin | 14 | 2015 | 562 | 0.480 |
Why?
|
| Choline O-Acetyltransferase | 15 | 2012 | 156 | 0.480 |
Why?
|
| Names | 1 | 2015 | 54 | 0.480 |
Why?
|
| Data Interpretation, Statistical | 4 | 2020 | 2693 | 0.470 |
Why?
|
| Histamine | 5 | 2019 | 496 | 0.470 |
Why?
|
| Male | 167 | 2024 | 364142 | 0.470 |
Why?
|
| Food | 3 | 2008 | 764 | 0.470 |
Why?
|
| Mice, Transgenic | 12 | 2020 | 9547 | 0.470 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 197 | 0.470 |
Why?
|
| Nervous System Diseases | 3 | 2015 | 1659 | 0.460 |
Why?
|
| Green Fluorescent Proteins | 11 | 2015 | 2062 | 0.450 |
Why?
|
| Sleep Stages | 6 | 2019 | 705 | 0.450 |
Why?
|
| Rats, Inbred Strains | 35 | 1992 | 2078 | 0.450 |
Why?
|
| Hypothalamus, Posterior | 3 | 2017 | 12 | 0.450 |
Why?
|
| Brain Mapping | 35 | 2018 | 6596 | 0.450 |
Why?
|
| Presynaptic Terminals | 5 | 2013 | 299 | 0.440 |
Why?
|
| Biotin | 6 | 2015 | 255 | 0.440 |
Why?
|
| Neurotransmitter Agents | 5 | 2014 | 661 | 0.440 |
Why?
|
| Thermogenesis | 1 | 2018 | 495 | 0.440 |
Why?
|
| Hydrocephalus | 1 | 2020 | 766 | 0.440 |
Why?
|
| Deception | 1 | 2014 | 99 | 0.440 |
Why?
|
| Acetylcholinesterase | 6 | 2004 | 151 | 0.430 |
Why?
|
| Dopamine | 6 | 2009 | 1581 | 0.420 |
Why?
|
| Economic Recession | 1 | 2014 | 79 | 0.420 |
Why?
|
| Financing, Organized | 1 | 2014 | 202 | 0.420 |
Why?
|
| Energy Metabolism | 5 | 2014 | 2903 | 0.420 |
Why?
|
| Deductibles and Coinsurance | 1 | 2015 | 315 | 0.410 |
Why?
|
| Stilbamidines | 4 | 2003 | 43 | 0.410 |
Why?
|
| Corpus Striatum | 7 | 2010 | 1218 | 0.410 |
Why?
|
| Respiration | 6 | 2024 | 1654 | 0.410 |
Why?
|
| Light | 6 | 2014 | 1358 | 0.400 |
Why?
|
| Raphe Nuclei | 4 | 2009 | 104 | 0.390 |
Why?
|
| Electromyography | 12 | 2018 | 1398 | 0.390 |
Why?
|
| Axonal Transport | 11 | 2002 | 178 | 0.390 |
Why?
|
| Neurobiology | 1 | 2013 | 135 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 23 | 2024 | 22352 | 0.380 |
Why?
|
| Peer Review | 1 | 2014 | 218 | 0.380 |
Why?
|
| Brain Chemistry | 10 | 2003 | 951 | 0.380 |
Why?
|
| Authorship | 1 | 2015 | 289 | 0.380 |
Why?
|
| Sympathetic Nervous System | 5 | 2006 | 520 | 0.380 |
Why?
|
| Inflammation | 8 | 2020 | 10860 | 0.380 |
Why?
|
| Societies, Medical | 3 | 2019 | 3957 | 0.370 |
Why?
|
| Work Schedule Tolerance | 1 | 2015 | 553 | 0.370 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 5 | 2020 | 63 | 0.370 |
Why?
|
| Serotonin | 2 | 2020 | 1045 | 0.360 |
Why?
|
| Circadian Clocks | 1 | 2013 | 170 | 0.360 |
Why?
|
| Retinal Ganglion Cells | 4 | 2014 | 810 | 0.360 |
Why?
|
| Optic Nerve | 1 | 2014 | 568 | 0.350 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 342 | 0.350 |
Why?
|
| Eating | 6 | 2007 | 1539 | 0.340 |
Why?
|
| Parkinson Disease | 10 | 2019 | 2884 | 0.340 |
Why?
|
| Women | 1 | 2011 | 225 | 0.330 |
Why?
|
| Immune System | 2 | 2010 | 800 | 0.330 |
Why?
|
| Catecholamines | 8 | 2009 | 388 | 0.330 |
Why?
|
| Sexual Behavior | 2 | 2021 | 2192 | 0.330 |
Why?
|
| Sensation | 3 | 2002 | 331 | 0.330 |
Why?
|
| Neuroendocrinology | 1 | 2009 | 5 | 0.320 |
Why?
|
| Conflict of Interest | 1 | 2014 | 556 | 0.320 |
Why?
|
| Electroencephalography | 19 | 2019 | 6282 | 0.320 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2009 | 69 | 0.320 |
Why?
|
| Lewy Body Disease | 2 | 2015 | 252 | 0.320 |
Why?
|
| Receptors, Neuropeptide | 3 | 2007 | 106 | 0.320 |
Why?
|
| Prosencephalon | 5 | 2017 | 305 | 0.310 |
Why?
|
| Ibotenic Acid | 6 | 2011 | 59 | 0.310 |
Why?
|
| In Situ Hybridization | 15 | 2010 | 1892 | 0.310 |
Why?
|
| Tegmentum Mesencephali | 10 | 2006 | 59 | 0.310 |
Why?
|
| Staining and Labeling | 6 | 2010 | 1075 | 0.310 |
Why?
|
| RNA, Messenger | 24 | 2006 | 12791 | 0.300 |
Why?
|
| Anesthesia | 3 | 2008 | 1595 | 0.300 |
Why?
|
| Multiple System Atrophy | 3 | 2015 | 132 | 0.300 |
Why?
|
| Interinstitutional Relations | 1 | 2009 | 235 | 0.300 |
Why?
|
| Basal Ganglia | 7 | 2005 | 549 | 0.300 |
Why?
|
| Nerve Degeneration | 8 | 2010 | 748 | 0.300 |
Why?
|
| Feeding Behavior | 9 | 2013 | 3208 | 0.290 |
Why?
|
| Nerve Regeneration | 1 | 2013 | 796 | 0.290 |
Why?
|
| Leptin | 12 | 2012 | 1596 | 0.290 |
Why?
|
| Viscera | 5 | 2000 | 138 | 0.290 |
Why?
|
| Dextrans | 6 | 2015 | 574 | 0.290 |
Why?
|
| Motor Neurons | 5 | 2015 | 869 | 0.280 |
Why?
|
| Diencephalon | 4 | 2001 | 54 | 0.280 |
Why?
|
| Rest | 4 | 2018 | 940 | 0.280 |
Why?
|
| Printing | 1 | 2007 | 47 | 0.280 |
Why?
|
| Microinjections | 9 | 2012 | 319 | 0.280 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2014 | 361 | 0.280 |
Why?
|
| Models, Neurological | 7 | 2009 | 1747 | 0.280 |
Why?
|
| Drug Costs | 1 | 2015 | 1195 | 0.280 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 8 | 2013 | 36 | 0.280 |
Why?
|
| Carrier Proteins | 7 | 2003 | 4924 | 0.270 |
Why?
|
| Dependovirus | 6 | 2012 | 720 | 0.270 |
Why?
|
| Excitatory Postsynaptic Potentials | 6 | 2018 | 369 | 0.270 |
Why?
|
| Light Signal Transduction | 2 | 2003 | 31 | 0.270 |
Why?
|
| History, 20th Century | 4 | 2016 | 2764 | 0.260 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 2 | 2016 | 40 | 0.260 |
Why?
|
| Color | 1 | 2007 | 297 | 0.260 |
Why?
|
| Benzhydryl Compounds | 3 | 2004 | 944 | 0.250 |
Why?
|
| Trigeminal Nucleus, Spinal | 3 | 1995 | 21 | 0.250 |
Why?
|
| Antigens | 6 | 2008 | 1441 | 0.250 |
Why?
|
| Internship and Residency | 2 | 2016 | 5943 | 0.250 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 1188 | 0.250 |
Why?
|
| Hypothalamus, Anterior | 3 | 2001 | 12 | 0.240 |
Why?
|
| Hamartoma | 2 | 2021 | 235 | 0.240 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 2 | 2019 | 17 | 0.240 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 1804 | 0.240 |
Why?
|
| alpha-Synuclein | 2 | 2015 | 771 | 0.240 |
Why?
|
| Signal Transduction | 8 | 2024 | 23619 | 0.240 |
Why?
|
| Adenosine | 4 | 2006 | 813 | 0.230 |
Why?
|
| Motivation | 2 | 2023 | 2020 | 0.230 |
Why?
|
| Phytohemagglutinins | 7 | 2012 | 164 | 0.230 |
Why?
|
| Neurofibrillary Tangles | 4 | 1996 | 457 | 0.230 |
Why?
|
| Cerebral Arteries | 3 | 1991 | 490 | 0.230 |
Why?
|
| Homeostasis | 8 | 2015 | 3342 | 0.230 |
Why?
|
| Gene Expression | 8 | 2016 | 7585 | 0.230 |
Why?
|
| Interneurons | 4 | 2010 | 592 | 0.230 |
Why?
|
| Synapses | 4 | 2009 | 1759 | 0.230 |
Why?
|
| Cyclooxygenase 2 | 5 | 2010 | 596 | 0.230 |
Why?
|
| Blood Pressure | 8 | 2015 | 8533 | 0.220 |
Why?
|
| Art | 1 | 2024 | 65 | 0.220 |
Why?
|
| Neural Inhibition | 8 | 2013 | 589 | 0.220 |
Why?
|
| Emotions | 3 | 2005 | 2758 | 0.220 |
Why?
|
| Ascomycota | 1 | 2024 | 82 | 0.220 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 3 | 2019 | 44 | 0.210 |
Why?
|
| Students, Medical | 1 | 2016 | 1962 | 0.210 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2007 | 1245 | 0.210 |
Why?
|
| Nerve Fibers | 7 | 1999 | 706 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2018 | 1104 | 0.210 |
Why?
|
| Genetic Vectors | 5 | 2013 | 3401 | 0.210 |
Why?
|
| Paintings | 1 | 2024 | 102 | 0.210 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 956 | 0.210 |
Why?
|
| Cerebellum | 5 | 2022 | 1520 | 0.210 |
Why?
|
| Mice, Knockout | 13 | 2020 | 14471 | 0.210 |
Why?
|
| Cold Temperature | 2 | 2021 | 794 | 0.200 |
Why?
|
| Substantia Innominata | 4 | 2006 | 23 | 0.200 |
Why?
|
| Health Expenditures | 1 | 2015 | 2390 | 0.200 |
Why?
|
| Proteins | 7 | 1999 | 6002 | 0.200 |
Why?
|
| Philosophy | 1 | 2002 | 69 | 0.200 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2270 | 0.200 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2418 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2015 | 3242 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1144 | 0.190 |
Why?
|
| Putamen | 4 | 2010 | 288 | 0.190 |
Why?
|
| Isoenzymes | 3 | 2004 | 1688 | 0.190 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2003 | 203 | 0.190 |
Why?
|
| Functional Laterality | 4 | 2013 | 2243 | 0.190 |
Why?
|
| Activity Cycles | 1 | 2001 | 47 | 0.190 |
Why?
|
| Amygdala | 8 | 2000 | 1375 | 0.190 |
Why?
|
| Globus Pallidus | 4 | 2020 | 247 | 0.190 |
Why?
|
| History, 21st Century | 3 | 2014 | 1574 | 0.190 |
Why?
|
| Acetylcholine | 4 | 2013 | 628 | 0.190 |
Why?
|
| Time Factors | 13 | 2018 | 40149 | 0.190 |
Why?
|
| Analgesics | 1 | 2008 | 1068 | 0.180 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 4421 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 1446 | 0.180 |
Why?
|
| Transduction, Genetic | 2 | 2015 | 899 | 0.180 |
Why?
|
| Acoustic Stimulation | 2 | 2017 | 1253 | 0.180 |
Why?
|
| Stress, Psychological | 3 | 2020 | 4527 | 0.180 |
Why?
|
| Sheep | 5 | 1996 | 1448 | 0.180 |
Why?
|
| Reticular Formation | 9 | 2006 | 60 | 0.180 |
Why?
|
| Specific Pathogen-Free Organisms | 7 | 2019 | 220 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3681 | 0.180 |
Why?
|
| Luminescent Proteins | 4 | 2013 | 839 | 0.180 |
Why?
|
| Limbic System | 7 | 1996 | 418 | 0.170 |
Why?
|
| Cognition | 4 | 2015 | 7057 | 0.170 |
Why?
|
| Caudate Nucleus | 4 | 2010 | 388 | 0.170 |
Why?
|
| Period Circadian Proteins | 2 | 2012 | 97 | 0.170 |
Why?
|
| Horseradish Peroxidase | 13 | 1991 | 169 | 0.170 |
Why?
|
| Mesencephalon | 9 | 2009 | 337 | 0.170 |
Why?
|
| Trigeminal Nuclei | 2 | 2001 | 39 | 0.170 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2017 | 982 | 0.170 |
Why?
|
| Female | 47 | 2021 | 396520 | 0.170 |
Why?
|
| Vagus Nerve | 4 | 2014 | 458 | 0.170 |
Why?
|
| Psychophysiology | 1 | 2000 | 136 | 0.170 |
Why?
|
| Body Weight | 5 | 2012 | 4626 | 0.160 |
Why?
|
| Brain Diseases | 3 | 2016 | 1552 | 0.160 |
Why?
|
| Histocytochemistry | 10 | 1999 | 697 | 0.160 |
Why?
|
| Cardiovascular System | 5 | 1992 | 839 | 0.160 |
Why?
|
| Receptor, Adenosine A1 | 3 | 2009 | 42 | 0.160 |
Why?
|
| Cats | 7 | 2011 | 972 | 0.160 |
Why?
|
| Electric Stimulation | 6 | 2011 | 1736 | 0.160 |
Why?
|
| Ethics, Professional | 1 | 1999 | 100 | 0.160 |
Why?
|
| Memory | 3 | 2005 | 2192 | 0.160 |
Why?
|
| Polyradiculoneuropathy | 1 | 1999 | 65 | 0.160 |
Why?
|
| Antibody Specificity | 4 | 2008 | 1062 | 0.160 |
Why?
|
| Respiratory Center | 2 | 2014 | 18 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3609 | 0.160 |
Why?
|
| Cholecystokinin | 4 | 2006 | 114 | 0.160 |
Why?
|
| Longevity | 1 | 2006 | 1083 | 0.160 |
Why?
|
| Tuberculosis, Meningeal | 1 | 1999 | 49 | 0.150 |
Why?
|
| Aging | 5 | 2014 | 8731 | 0.150 |
Why?
|
| Cerebral Ventricles | 5 | 2003 | 550 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7431 | 0.150 |
Why?
|
| Tolmetin | 1 | 1998 | 24 | 0.150 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2020 | 326 | 0.150 |
Why?
|
| Motor Neuron Disease | 1 | 1999 | 98 | 0.150 |
Why?
|
| Acute-Phase Reaction | 2 | 1996 | 91 | 0.150 |
Why?
|
| Reflex, Abnormal | 1 | 1998 | 83 | 0.150 |
Why?
|
| Injections, Intravenous | 5 | 1998 | 1377 | 0.150 |
Why?
|
| Eye Movements | 2 | 2013 | 510 | 0.150 |
Why?
|
| Rats, Wistar | 6 | 2013 | 1889 | 0.150 |
Why?
|
| State Medicine | 1 | 2019 | 219 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3967 | 0.150 |
Why?
|
| Behavior, Animal | 4 | 2016 | 1865 | 0.150 |
Why?
|
| Receptors, Opioid, mu | 1 | 1999 | 167 | 0.150 |
Why?
|
| Thalamus | 7 | 2011 | 1040 | 0.150 |
Why?
|
| Primates | 2 | 2000 | 519 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 3 | 2017 | 924 | 0.150 |
Why?
|
| Research | 1 | 2006 | 1977 | 0.150 |
Why?
|
| tau Proteins | 4 | 1996 | 2107 | 0.140 |
Why?
|
| Computer Graphics | 1 | 1999 | 345 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2006 | 2258 | 0.140 |
Why?
|
| Glutamate Decarboxylase | 5 | 2019 | 239 | 0.140 |
Why?
|
| Receptors, GABA-A | 3 | 2008 | 624 | 0.140 |
Why?
|
| Receptors, Cell Surface | 3 | 2009 | 2815 | 0.140 |
Why?
|
| Corticosterone | 1 | 2018 | 301 | 0.140 |
Why?
|
| Fluorescent Dyes | 10 | 2003 | 1927 | 0.140 |
Why?
|
| Pain | 5 | 2009 | 5098 | 0.140 |
Why?
|
| Physicians | 1 | 2015 | 4591 | 0.140 |
Why?
|
| Haplorhini | 5 | 1993 | 520 | 0.140 |
Why?
|
| Meningeal Arteries | 1 | 1997 | 66 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3581 | 0.140 |
Why?
|
| Repressor Proteins | 4 | 2024 | 2978 | 0.140 |
Why?
|
| Dementia | 1 | 2011 | 2741 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 10 | 1999 | 2470 | 0.130 |
Why?
|
| Neurofibrils | 4 | 1994 | 75 | 0.130 |
Why?
|
| Okadaic Acid | 1 | 1996 | 67 | 0.130 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2009 | 1897 | 0.130 |
Why?
|
| Microscopy, Electron | 6 | 2012 | 2551 | 0.130 |
Why?
|
| Photography | 1 | 1999 | 536 | 0.130 |
Why?
|
| Fatigue | 1 | 2023 | 1555 | 0.130 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2645 | 0.130 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1996 | 262 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5368 | 0.130 |
Why?
|
| Stress, Physiological | 2 | 2018 | 1406 | 0.130 |
Why?
|
| Wheat Germ Agglutinins | 9 | 1991 | 47 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 3 | 1992 | 239 | 0.130 |
Why?
|
| Bibliometrics | 1 | 1999 | 355 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9525 | 0.130 |
Why?
|
| Transgenes | 2 | 1998 | 1014 | 0.120 |
Why?
|
| Reward | 1 | 2002 | 980 | 0.120 |
Why?
|
| Cerebellar Nuclei | 1 | 1995 | 54 | 0.120 |
Why?
|
| Motor Cortex | 3 | 1996 | 1004 | 0.120 |
Why?
|
| Hypertension | 1 | 2015 | 8616 | 0.120 |
Why?
|
| Parasympathetic Nervous System | 2 | 1994 | 144 | 0.120 |
Why?
|
| Reference Standards | 2 | 2015 | 1010 | 0.120 |
Why?
|
| Thalamic Nuclei | 5 | 1989 | 110 | 0.120 |
Why?
|
| Stroke | 3 | 2015 | 9741 | 0.120 |
Why?
|
| Interleukin-1 | 2 | 2010 | 1251 | 0.120 |
Why?
|
| Thiazines | 1 | 2014 | 38 | 0.120 |
Why?
|
| Darkness | 4 | 2003 | 159 | 0.120 |
Why?
|
| Myocardium | 3 | 2006 | 4765 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 244 | 0.120 |
Why?
|
| United States | 7 | 2019 | 72951 | 0.120 |
Why?
|
| Hypotension, Orthostatic | 1 | 1998 | 258 | 0.120 |
Why?
|
| Tourette Syndrome | 2 | 2010 | 400 | 0.120 |
Why?
|
| Hypothermia | 1 | 1996 | 189 | 0.120 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 1998 | 371 | 0.120 |
Why?
|
| Ventriculostomy | 1 | 2016 | 132 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1990 | 362 | 0.110 |
Why?
|
| Retina | 2 | 2010 | 2660 | 0.110 |
Why?
|
| Neurites | 1 | 1996 | 389 | 0.110 |
Why?
|
| Ventral Thalamic Nuclei | 2 | 2005 | 43 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2019 | 811 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 334 | 0.110 |
Why?
|
| Prefrontal Cortex | 4 | 2013 | 2224 | 0.110 |
Why?
|
| Gene Transfer Techniques | 2 | 2009 | 1206 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 2059 | 0.110 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 91 | 0.110 |
Why?
|
| Anesthetics | 4 | 2007 | 525 | 0.110 |
Why?
|
| Aged, 80 and over | 10 | 2015 | 59550 | 0.110 |
Why?
|
| Carbachol | 1 | 2013 | 223 | 0.110 |
Why?
|
| Insulin | 2 | 2022 | 6608 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 911 | 0.110 |
Why?
|
| Silver Staining | 3 | 2002 | 63 | 0.110 |
Why?
|
| Thiazoles | 4 | 2014 | 1529 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18330 | 0.110 |
Why?
|
| Plethysmography | 1 | 2013 | 172 | 0.100 |
Why?
|
| Adrenergic Fibers | 2 | 1992 | 21 | 0.100 |
Why?
|
| Coma | 1 | 2016 | 485 | 0.100 |
Why?
|
| Cataplexy | 1 | 2013 | 62 | 0.100 |
Why?
|
| Sensation Disorders | 1 | 2014 | 160 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1994 | 4349 | 0.100 |
Why?
|
| Genes, fos | 2 | 2011 | 176 | 0.100 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 2 | 2003 | 9 | 0.100 |
Why?
|
| Organ Specificity | 5 | 2006 | 1966 | 0.100 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2012 | 74 | 0.100 |
Why?
|
| Pyrogens | 1 | 1992 | 17 | 0.100 |
Why?
|
| Denervation | 2 | 2006 | 265 | 0.100 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 2011 | 142 | 0.100 |
Why?
|
| Cacao | 1 | 2013 | 98 | 0.100 |
Why?
|
| Diphtheria Toxin | 1 | 2013 | 253 | 0.100 |
Why?
|
| Tissue Fixation | 2 | 2008 | 245 | 0.100 |
Why?
|
| Axons | 5 | 2010 | 1675 | 0.100 |
Why?
|
| Electric Stimulation Therapy | 1 | 1998 | 635 | 0.100 |
Why?
|
| Aged | 28 | 2021 | 171343 | 0.100 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 128 | 0.100 |
Why?
|
| Obesity | 3 | 2022 | 13090 | 0.100 |
Why?
|
| Laughter | 1 | 2011 | 19 | 0.100 |
Why?
|
| Action Potentials | 6 | 2019 | 1835 | 0.100 |
Why?
|
| Neurons, Afferent | 3 | 1991 | 498 | 0.100 |
Why?
|
| Publications | 1 | 2014 | 195 | 0.100 |
Why?
|
| Environment | 2 | 2010 | 1120 | 0.100 |
Why?
|
| Time Perception | 1 | 2012 | 87 | 0.100 |
Why?
|
| Gait | 1 | 2017 | 823 | 0.100 |
Why?
|
| Microglia | 2 | 1998 | 1370 | 0.100 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1997 | 951 | 0.090 |
Why?
|
| Receptors, Corticotropin | 2 | 2003 | 24 | 0.090 |
Why?
|
| Glutamates | 1 | 1992 | 384 | 0.090 |
Why?
|
| Consensus | 2 | 2019 | 3208 | 0.090 |
Why?
|
| Copper | 1 | 2014 | 365 | 0.090 |
Why?
|
| Dendrites | 5 | 2010 | 471 | 0.090 |
Why?
|
| Water | 1 | 2017 | 1417 | 0.090 |
Why?
|
| Ghrelin | 1 | 2012 | 254 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 490 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2014 | 412 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 3 | 2010 | 1089 | 0.090 |
Why?
|
| Telencephalon | 3 | 1986 | 142 | 0.090 |
Why?
|
| Cyclooxygenase 1 | 2 | 2016 | 98 | 0.090 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 11920 | 0.090 |
Why?
|
| Sexual Behavior, Animal | 1 | 2011 | 120 | 0.080 |
Why?
|
| Anesthetics, General | 1 | 2011 | 151 | 0.080 |
Why?
|
| Accidental Falls | 1 | 1998 | 1078 | 0.080 |
Why?
|
| Dynorphins | 3 | 2005 | 82 | 0.080 |
Why?
|
| Xanthines | 1 | 2009 | 121 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2016 | 1259 | 0.080 |
Why?
|
| Injections, Intraventricular | 4 | 2003 | 227 | 0.080 |
Why?
|
| Oncogene Proteins v-fos | 2 | 2009 | 15 | 0.080 |
Why?
|
| Starvation | 2 | 2008 | 141 | 0.080 |
Why?
|
| Schizophrenia | 4 | 2005 | 6976 | 0.080 |
Why?
|
| Delta Rhythm | 2 | 2019 | 81 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2013 | 1093 | 0.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 6 | 2010 | 367 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2003 | 10745 | 0.080 |
Why?
|
| Pro-Opiomelanocortin | 2 | 1999 | 139 | 0.080 |
Why?
|
| Blood-Brain Barrier | 2 | 2010 | 1028 | 0.080 |
Why?
|
| Epilepsy | 2 | 2021 | 3317 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2020 | 9661 | 0.080 |
Why?
|
| Isoflurane | 1 | 2011 | 383 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 1996 | 1892 | 0.070 |
Why?
|
| Reaction Time | 2 | 2013 | 2085 | 0.070 |
Why?
|
| DNA Primers | 3 | 1998 | 2826 | 0.070 |
Why?
|
| Protein Precursors | 3 | 2001 | 1134 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2022 | 36567 | 0.070 |
Why?
|
| ARNTL Transcription Factors | 1 | 2008 | 99 | 0.070 |
Why?
|
| Neuropeptide Y | 3 | 1999 | 194 | 0.070 |
Why?
|
| Frontal Lobe | 3 | 1990 | 1408 | 0.070 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 125 | 0.070 |
Why?
|
| Avoidance Learning | 1 | 2009 | 248 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 1999 | 8926 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2002 | 835 | 0.070 |
Why?
|
| Autoradiography | 8 | 1988 | 725 | 0.070 |
Why?
|
| Superior Colliculi | 3 | 2003 | 97 | 0.070 |
Why?
|
| Theta Rhythm | 2 | 2019 | 220 | 0.070 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2006 | 8 | 0.070 |
Why?
|
| Facial Muscles | 1 | 1987 | 159 | 0.070 |
Why?
|
| Integrases | 4 | 2014 | 520 | 0.070 |
Why?
|
| Endorphins | 1 | 1986 | 73 | 0.070 |
Why?
|
| Sleep Paralysis | 1 | 2006 | 15 | 0.070 |
Why?
|
| Adult | 26 | 2018 | 223307 | 0.070 |
Why?
|
| Peptides | 3 | 2003 | 4344 | 0.070 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1986 | 25 | 0.070 |
Why?
|
| Syndrome | 1 | 2012 | 3271 | 0.060 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 1985 | 18 | 0.060 |
Why?
|
| Cytokines | 2 | 1998 | 7438 | 0.060 |
Why?
|
| Food Deprivation | 1 | 2006 | 115 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 5 | 1996 | 9244 | 0.060 |
Why?
|
| Middle Aged | 23 | 2016 | 223257 | 0.060 |
Why?
|
| Hyperventilation | 1 | 2005 | 78 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2006 | 456 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 771 | 0.060 |
Why?
|
| Sincalide | 1 | 1985 | 15 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2012 | 1004 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3721 | 0.060 |
Why?
|
| Substance P | 3 | 1997 | 331 | 0.060 |
Why?
|
| Paraplegia | 1 | 1986 | 161 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2012 | 6222 | 0.060 |
Why?
|
| Sweating | 1 | 1986 | 155 | 0.060 |
Why?
|
| Systems Biology | 1 | 2008 | 481 | 0.060 |
Why?
|
| Temperature | 3 | 2005 | 2233 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2007 | 252 | 0.060 |
Why?
|
| Dura Mater | 2 | 2010 | 292 | 0.060 |
Why?
|
| Reflex | 2 | 1986 | 375 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 2 | 2003 | 1193 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6214 | 0.060 |
Why?
|
| Violence | 1 | 2011 | 931 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3796 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 410 | 0.060 |
Why?
|
| Dreams | 1 | 2005 | 145 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2006 | 789 | 0.060 |
Why?
|
| Extrapyramidal Tracts | 2 | 1987 | 17 | 0.060 |
Why?
|
| Enkephalin, Methionine | 2 | 1997 | 26 | 0.060 |
Why?
|
| Adenosine Deaminase | 2 | 2004 | 253 | 0.060 |
Why?
|
| Benzothiazoles | 3 | 1994 | 244 | 0.060 |
Why?
|
| Death, Sudden | 1 | 2006 | 301 | 0.060 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2004 | 77 | 0.060 |
Why?
|
| Macaca mulatta | 3 | 2002 | 2341 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 2 | 1995 | 316 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 4 | 1992 | 1697 | 0.060 |
Why?
|
| Tectum Mesencephali | 1 | 2003 | 18 | 0.060 |
Why?
|
| Turpentine | 1 | 2003 | 10 | 0.060 |
Why?
|
| Immunochemistry | 3 | 1991 | 116 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2004 | 102 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4424 | 0.050 |
Why?
|
| Irritants | 1 | 2003 | 42 | 0.050 |
Why?
|
| Geniculate Bodies | 2 | 2003 | 157 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 2 | 1996 | 3887 | 0.050 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2003 | 108 | 0.050 |
Why?
|
| Synaptic Membranes | 1 | 2003 | 88 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 541 | 0.050 |
Why?
|
| Neurotensin | 3 | 2000 | 59 | 0.050 |
Why?
|
| Syringes | 1 | 1983 | 58 | 0.050 |
Why?
|
| Blotting, Western | 4 | 1997 | 5022 | 0.050 |
Why?
|
| Muscle Proteins | 2 | 1985 | 1160 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 1995 | 1750 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 3853 | 0.050 |
Why?
|
| Sensory Receptor Cells | 1 | 1987 | 509 | 0.050 |
Why?
|
| Pressoreceptors | 2 | 1998 | 98 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 8540 | 0.050 |
Why?
|
| Species Specificity | 5 | 2001 | 2413 | 0.050 |
Why?
|
| Weight Gain | 1 | 2012 | 2356 | 0.050 |
Why?
|
| International Cooperation | 1 | 2009 | 1434 | 0.050 |
Why?
|
| Angina Pectoris | 1 | 2006 | 956 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2003 | 177 | 0.050 |
Why?
|
| Receptors, Glucagon | 1 | 2002 | 90 | 0.050 |
Why?
|
| Macrophages | 1 | 1997 | 5783 | 0.050 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2003 | 92 | 0.050 |
Why?
|
| Biogenic Monoamines | 1 | 2002 | 50 | 0.050 |
Why?
|
| Venoms | 1 | 2002 | 94 | 0.050 |
Why?
|
| Aotidae | 1 | 2002 | 57 | 0.050 |
Why?
|
| Confidentiality | 1 | 2006 | 607 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4249 | 0.050 |
Why?
|
| Lectins | 4 | 1991 | 490 | 0.050 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2001 | 18 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 14652 | 0.050 |
Why?
|
| Nociceptors | 2 | 2006 | 460 | 0.050 |
Why?
|
| Cost Savings | 1 | 2007 | 902 | 0.050 |
Why?
|
| Research Design | 2 | 2009 | 6207 | 0.050 |
Why?
|
| Ion Channels | 1 | 2006 | 1043 | 0.050 |
Why?
|
| Necrosis | 1 | 2006 | 1616 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 684 | 0.050 |
Why?
|
| Thermosensing | 1 | 2001 | 56 | 0.050 |
Why?
|
| Receptors, Somatostatin | 2 | 1992 | 138 | 0.050 |
Why?
|
| Methyl Ethers | 1 | 2003 | 196 | 0.050 |
Why?
|
| Lipids | 1 | 2012 | 3319 | 0.050 |
Why?
|
| Synaptic Vesicles | 1 | 2003 | 187 | 0.050 |
Why?
|
| Photoperiod | 1 | 2002 | 141 | 0.050 |
Why?
|
| Oculomotor Nerve | 2 | 1978 | 72 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 319 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 292 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2001 | 39 | 0.050 |
Why?
|
| Dopamine Agonists | 1 | 2003 | 346 | 0.050 |
Why?
|
| Troponin T | 1 | 2006 | 786 | 0.050 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2000 | 48 | 0.050 |
Why?
|
| Stimulation, Chemical | 2 | 1998 | 305 | 0.050 |
Why?
|
| Massachusetts | 1 | 2014 | 8891 | 0.050 |
Why?
|
| Parietal Lobe | 1 | 2006 | 859 | 0.050 |
Why?
|
| Genes, Reporter | 3 | 2003 | 1525 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 22248 | 0.040 |
Why?
|
| Anorexia | 1 | 2001 | 153 | 0.040 |
Why?
|
| Hypothalamus, Middle | 2 | 1979 | 15 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2006 | 1075 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 980 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 26310 | 0.040 |
Why?
|
| Tuber Cinereum | 1 | 2000 | 1 | 0.040 |
Why?
|
| Receptors, Leptin | 2 | 2000 | 352 | 0.040 |
Why?
|
| Consciousness | 2 | 2005 | 602 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2018 | 41710 | 0.040 |
Why?
|
| Rodentia | 1 | 2002 | 262 | 0.040 |
Why?
|
| GABA Antagonists | 3 | 2007 | 119 | 0.040 |
Why?
|
| Amidines | 2 | 1991 | 28 | 0.040 |
Why?
|
| Receptors, Melanocortin | 1 | 1999 | 23 | 0.040 |
Why?
|
| Hyperthermia, Induced | 1 | 2003 | 414 | 0.040 |
Why?
|
| Transcription, Genetic | 5 | 2004 | 7609 | 0.040 |
Why?
|
| Satiety Response | 1 | 1999 | 47 | 0.040 |
Why?
|
| District of Columbia | 1 | 2019 | 159 | 0.040 |
Why?
|
| Somatostatin | 2 | 1993 | 459 | 0.040 |
Why?
|
| Migraine Disorders | 2 | 2010 | 1710 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 7119 | 0.040 |
Why?
|
| Lumbosacral Plexus | 1 | 1999 | 53 | 0.040 |
Why?
|
| Neurosecretory Systems | 1 | 2000 | 223 | 0.040 |
Why?
|
| Olfactory Pathways | 1 | 2000 | 131 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2005 | 945 | 0.040 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1980 | 166 | 0.040 |
Why?
|
| Smoking | 1 | 1995 | 9077 | 0.040 |
Why?
|
| Medical Illustration | 1 | 1999 | 134 | 0.040 |
Why?
|
| RNA Probes | 1 | 1998 | 110 | 0.040 |
Why?
|
| Movement | 1 | 2005 | 1468 | 0.040 |
Why?
|
| Dexmedetomidine | 1 | 2003 | 321 | 0.040 |
Why?
|
| Lysine | 3 | 1997 | 997 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 4 | 2008 | 2629 | 0.040 |
Why?
|
| Electrodiagnosis | 1 | 1999 | 149 | 0.040 |
Why?
|
| Information Services | 1 | 1999 | 239 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2012 | 6422 | 0.040 |
Why?
|
| Recombination, Genetic | 2 | 2003 | 1525 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2024 | 2510 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2003 | 1263 | 0.040 |
Why?
|
| Heart Rate | 3 | 2002 | 4207 | 0.040 |
Why?
|
| Transcription Factors | 4 | 2008 | 12150 | 0.040 |
Why?
|
| Sex Factors | 1 | 2011 | 10619 | 0.040 |
Why?
|
| Neural Conduction | 1 | 1999 | 442 | 0.040 |
Why?
|
| Ketorolac | 1 | 1998 | 95 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2017 | 175 | 0.030 |
Why?
|
| Carbocyanines | 1 | 1997 | 177 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2677 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2016 | 276 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 20144 | 0.030 |
Why?
|
| Confusion | 1 | 1999 | 278 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 1982 | 588 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3439 | 0.030 |
Why?
|
| Autonomic Pathways | 1 | 1996 | 31 | 0.030 |
Why?
|
| Social Responsibility | 1 | 1999 | 382 | 0.030 |
Why?
|
| Social Behavior | 1 | 2003 | 1147 | 0.030 |
Why?
|
| Goats | 1 | 1996 | 166 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1998 | 265 | 0.030 |
Why?
|
| Excitatory Amino Acids | 1 | 1995 | 17 | 0.030 |
Why?
|
| Base Sequence | 3 | 1996 | 12415 | 0.030 |
Why?
|
| Immune Sera | 2 | 1987 | 605 | 0.030 |
Why?
|
| Adenosine A1 Receptor Antagonists | 2 | 2006 | 27 | 0.030 |
Why?
|
| History, 17th Century | 1 | 1995 | 108 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 5795 | 0.030 |
Why?
|
| Tissue Distribution | 5 | 2006 | 2275 | 0.030 |
Why?
|
| Perception | 1 | 2002 | 1204 | 0.030 |
Why?
|
| Benzidines | 2 | 1985 | 6 | 0.030 |
Why?
|
| Software | 2 | 2001 | 4466 | 0.030 |
Why?
|
| Membrane Proteins | 3 | 2016 | 7868 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2001 | 1989 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18397 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1996 | 2746 | 0.030 |
Why?
|
| Nucleus Accumbens | 1 | 1997 | 360 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2006 | 2654 | 0.030 |
Why?
|
| Neurons, Efferent | 3 | 1979 | 81 | 0.030 |
Why?
|
| Visual Pathways | 1 | 1999 | 554 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2976 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1996 | 17608 | 0.030 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2013 | 17 | 0.030 |
Why?
|
| Diprenorphine | 1 | 1993 | 13 | 0.030 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1996 | 415 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1838 | 0.030 |
Why?
|
| Autopsy | 1 | 1998 | 1011 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 2 | 1985 | 326 | 0.030 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 109 | 0.030 |
Why?
|
| Chronic Disease | 2 | 1999 | 9357 | 0.030 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2013 | 37 | 0.030 |
Why?
|
| Melatonin | 2 | 2013 | 670 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2011 | 13050 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 1998 | 594 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 367 | 0.030 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2013 | 90 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 12985 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 4168 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2003 | 1982 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 390 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2000 | 882 | 0.030 |
Why?
|
| Gyrus Cinguli | 4 | 1997 | 1118 | 0.030 |
Why?
|
| Methyltyrosines | 1 | 1973 | 7 | 0.030 |
Why?
|
| Sacrum | 1 | 2015 | 273 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1993 | 43 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2009 | 8066 | 0.030 |
Why?
|
| Clonazepam | 1 | 2013 | 135 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 1993 | 224 | 0.030 |
Why?
|
| Multigene Family | 1 | 1996 | 1081 | 0.030 |
Why?
|
| Swine | 2 | 1995 | 5987 | 0.030 |
Why?
|
| GABA Modulators | 1 | 2013 | 108 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2000 | 1193 | 0.030 |
Why?
|
| Cell Line | 2 | 2016 | 15563 | 0.030 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 1992 | 8 | 0.030 |
Why?
|
| Saimiri | 3 | 1979 | 337 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1993 | 816 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2003 | 2030 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2006 | 3001 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2006 | 6408 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4853 | 0.030 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2003 | 86 | 0.030 |
Why?
|
| Macaca | 2 | 2009 | 413 | 0.030 |
Why?
|
| Receptors, N-Acetylglucosamine | 1 | 2012 | 11 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 1992 | 81 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 1994 | 348 | 0.020 |
Why?
|
| Cerebellar Cortex | 1 | 1993 | 108 | 0.020 |
Why?
|
| Vasopressins | 1 | 1993 | 358 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2012 | 103 | 0.020 |
Why?
|
| Olfactory Bulb | 2 | 1984 | 198 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6507 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 36461 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 1994 | 367 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2003 | 820 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1992 | 305 | 0.020 |
Why?
|
| Injections | 1 | 1994 | 839 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2228 | 0.020 |
Why?
|
| Ganglia | 1 | 1991 | 86 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1998 | 1275 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1994 | 564 | 0.020 |
Why?
|
| Adipocytes | 1 | 1998 | 1196 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 1751 | 0.020 |
Why?
|
| Fornix, Brain | 2 | 2001 | 71 | 0.020 |
Why?
|
| Shock | 1 | 1993 | 316 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 1973 | 276 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2004 | 178 | 0.020 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1992 | 154 | 0.020 |
Why?
|
| Headache | 1 | 1999 | 1260 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 14072 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 3815 | 0.020 |
Why?
|
| Pigmentation | 1 | 1991 | 143 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 1987 | 908 | 0.020 |
Why?
|
| Exons | 1 | 1996 | 2392 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 613 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 1992 | 227 | 0.020 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 850 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1996 | 2085 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4340 | 0.020 |
Why?
|
| Gold | 1 | 1993 | 480 | 0.020 |
Why?
|
| Walking | 1 | 2017 | 1201 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 2003 | 573 | 0.020 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 2 | 1987 | 18 | 0.020 |
Why?
|
| Appetitive Behavior | 1 | 2009 | 39 | 0.020 |
Why?
|
| Electroshock | 1 | 2009 | 120 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2012 | 562 | 0.020 |
Why?
|
| Renal Artery | 1 | 1990 | 355 | 0.020 |
Why?
|
| Biological Transport | 2 | 2000 | 2083 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1993 | 792 | 0.020 |
Why?
|
| Posture | 2 | 1999 | 955 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 372 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 1996 | 13411 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 2009 | 180 | 0.020 |
Why?
|
| Phenotype | 3 | 2012 | 16724 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 1998 | 1921 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1990 | 838 | 0.020 |
Why?
|
| Vasomotor System | 2 | 1987 | 208 | 0.020 |
Why?
|
| Tetanus Toxin | 1 | 1987 | 46 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1994 | 1313 | 0.020 |
Why?
|
| Weight Loss | 1 | 1999 | 2712 | 0.020 |
Why?
|
| Bicuculline | 1 | 2007 | 96 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6066 | 0.020 |
Why?
|
| Maze Learning | 1 | 2009 | 479 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1987 | 292 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10580 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9611 | 0.020 |
Why?
|
| Phenoxybenzamine | 1 | 1986 | 53 | 0.020 |
Why?
|
| Adenosine A1 Receptor Agonists | 1 | 2006 | 13 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2006 | 20 | 0.020 |
Why?
|
| Ganglia, Parasympathetic | 1 | 2006 | 18 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2007 | 204 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 368 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1982 | 3636 | 0.020 |
Why?
|
| Blindness | 1 | 2010 | 585 | 0.020 |
Why?
|
| Phenothiazines | 1 | 1985 | 60 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 2005 | 82 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2005 | 119 | 0.020 |
Why?
|
| Chromogenic Compounds | 1 | 1985 | 29 | 0.020 |
Why?
|
| Child | 3 | 2021 | 80668 | 0.020 |
Why?
|
| Leucine | 2 | 1976 | 547 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 11513 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 59939 | 0.020 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2006 | 130 | 0.020 |
Why?
|
| Proline | 2 | 1976 | 454 | 0.010 |
Why?
|
| Peroxidases | 1 | 1985 | 134 | 0.010 |
Why?
|
| Atrial Function | 1 | 1985 | 98 | 0.010 |
Why?
|
| Theophylline | 1 | 2005 | 133 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 684 | 0.010 |
Why?
|
| Heart Atria | 1 | 1990 | 1361 | 0.010 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2005 | 75 | 0.010 |
Why?
|
| Cell Death | 1 | 2010 | 1676 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 2011 | 1188 | 0.010 |
Why?
|
| Tristetraprolin | 1 | 2004 | 40 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 2478 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 9101 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1998 | 12430 | 0.010 |
Why?
|
| Supraoptic Nucleus | 2 | 1985 | 28 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1986 | 618 | 0.010 |
Why?
|
| Lithium Chloride | 1 | 2004 | 82 | 0.010 |
Why?
|
| Cues | 1 | 2009 | 877 | 0.010 |
Why?
|
| Epinephrine | 2 | 1985 | 782 | 0.010 |
Why?
|
| Body Fluids | 1 | 1985 | 321 | 0.010 |
Why?
|
| Septal Nuclei | 1 | 1984 | 82 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2006 | 534 | 0.010 |
Why?
|
| Microchemistry | 1 | 1983 | 54 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1986 | 551 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 616 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1432 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 1987 | 346 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1993 | 4188 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2746 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 2001 | 2093 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2003 | 69 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2600 | 0.010 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2002 | 59 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2003 | 171 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2003 | 240 | 0.010 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2003 | 131 | 0.010 |
Why?
|
| Adolescent | 4 | 2012 | 88904 | 0.010 |
Why?
|
| Tritium | 1 | 1982 | 707 | 0.010 |
Why?
|
| Septum Pellucidum | 1 | 1982 | 55 | 0.010 |
Why?
|
| GABA Agonists | 1 | 2002 | 106 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2011 | 42577 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 2672 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 577 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 11882 | 0.010 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2001 | 14 | 0.010 |
Why?
|
| Autoantibodies | 2 | 2005 | 2115 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 594 | 0.010 |
Why?
|
| Cell Survival | 1 | 1991 | 5748 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 444 | 0.010 |
Why?
|
| Pyridazines | 1 | 2003 | 199 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 10384 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2001 | 78 | 0.010 |
Why?
|
| Phenethylamines | 1 | 2001 | 95 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 624 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2000 | 108 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2121 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 128 | 0.010 |
Why?
|
| Cerebellar Ataxia | 1 | 1982 | 151 | 0.010 |
Why?
|
| Enkephalins | 1 | 2000 | 139 | 0.010 |
Why?
|
| Cytarabine | 1 | 1982 | 696 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2002 | 556 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2006 | 978 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1987 | 872 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 1999 | 133 | 0.010 |
Why?
|
| Medial Forebrain Bundle | 1 | 1979 | 42 | 0.010 |
Why?
|
| Methamphetamine | 1 | 2001 | 167 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 3587 | 0.010 |
Why?
|
| Dog Diseases | 1 | 1999 | 143 | 0.010 |
Why?
|
| Cerebral Aqueduct | 1 | 1978 | 39 | 0.010 |
Why?
|
| Agouti-Related Protein | 1 | 1998 | 95 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1990 | 3832 | 0.010 |
Why?
|
| Urination | 1 | 1979 | 204 | 0.010 |
Why?
|
| Postural Balance | 1 | 2003 | 637 | 0.010 |
Why?
|
| Antihypertensive Agents | 2 | 2001 | 2030 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 13036 | 0.010 |
Why?
|
| Lac Operon | 1 | 1997 | 237 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8045 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 1168 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1978 | 248 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13640 | 0.010 |
Why?
|
| Meninges | 1 | 1998 | 197 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 6287 | 0.010 |
Why?
|
| Visual Cortex | 1 | 1984 | 1081 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 1801 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2000 | 751 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1978 | 529 | 0.010 |
Why?
|
| Methotrexate | 1 | 1982 | 1719 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1999 | 771 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2003 | 1885 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 3834 | 0.010 |
Why?
|
| Bethanechol Compounds | 1 | 1993 | 10 | 0.010 |
Why?
|
| Enkephalin, Leucine | 1 | 1993 | 16 | 0.010 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1993 | 18 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 5199 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 15835 | 0.010 |
Why?
|
| Age of Onset | 1 | 1999 | 3342 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 774 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 1999 | 1647 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1993 | 339 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1982 | 6307 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9461 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 1657 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1998 | 65273 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 21525 | 0.010 |
Why?
|
| Naloxone | 1 | 1993 | 372 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1550 | 0.010 |
Why?
|
| Appetite | 1 | 1973 | 247 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3702 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 1991 | 235 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1999 | 6020 | 0.000 |
Why?
|
| Narcotic Antagonists | 1 | 1993 | 591 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1992 | 1472 | 0.000 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 946 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6359 | 0.000 |
Why?
|
| Rats, Inbred Lew | 1 | 1988 | 1168 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 74881 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 6962 | 0.000 |
Why?
|
| DNA | 2 | 1992 | 7208 | 0.000 |
Why?
|
| Natriuresis | 1 | 1985 | 106 | 0.000 |
Why?
|
| Occipital Lobe | 1 | 1987 | 376 | 0.000 |
Why?
|
| Substantia Nigra | 1 | 1987 | 346 | 0.000 |
Why?
|
| Thiocyanates | 1 | 1985 | 70 | 0.000 |
Why?
|
| Fluoresceins | 1 | 1985 | 235 | 0.000 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1985 | 220 | 0.000 |
Why?
|
| Renal Circulation | 1 | 1985 | 288 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1985 | 861 | 0.000 |
Why?
|
| Drug Stability | 1 | 1984 | 289 | 0.000 |
Why?
|
| Body Water | 1 | 1985 | 337 | 0.000 |
Why?
|
| Cyclic GMP | 1 | 1985 | 394 | 0.000 |
Why?
|
| Vestibular Nuclei | 1 | 1983 | 23 | 0.000 |
Why?
|
| Neoplasms | 1 | 1992 | 22350 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 81635 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1985 | 563 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1982 | 9404 | 0.000 |
Why?
|
| Renin | 1 | 1985 | 647 | 0.000 |
Why?
|
| Acute Disease | 1 | 1993 | 7241 | 0.000 |
Why?
|
| Cranial Nerves | 1 | 1983 | 97 | 0.000 |
Why?
|
| Sodium | 1 | 1985 | 1594 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1999 | 6869 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1982 | 20708 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1985 | 1540 | 0.000 |
Why?
|
| Kidney | 1 | 1985 | 7074 | 0.000 |
Why?
|